And with that, I will turn the call over to Don Wood to begin our discussion of our fourth quarter results. Don Wood: Thank ...

A two-point second quarter cost the Cheyenne Central boys during a 63-45 loss to fourth-ranked Thunder Basin on Friday night at the Central Fieldhouse.

The displays on the Galaxy Z Fold 7 and Flip 7 are tipped to be highly efficient, while the design of the Fold might not ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

H1 2024-25 results in line with expectations Operating verticals revenues of €600m up 3.9% like-for-like1 Adjusted EBITDA margin of 55.2% FY 2024-25 objectives confirmed ...

Shares of Palo Alto Networks (PANW) are down in after-hours trading after the cybersecurity company reported earnings for its ...

Joao Fonseca reached the quarter-finals at the 2025 Argentina Open in Buenos Aires after producing sensational level once again. It's very difficult not to get excited when Fonseca appears on the ...

Good morning, and welcome to the Conference Call for Tate & Lyle's Q3 Trading Statement. Your speakers today are Nick Hampton, Chief Executive; and Sarah Kuijlaars, Chief Financial Officer. I will now ...

For businesses, the transition from Q1 to Q2 can be critical. Your strides in the first quarter can lay the foundation for success in the upcoming months. As such, it’s important to strategize and ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

Follow all the latest UEFA Conference League 2024/2025 news from the official UEFA.com site. Includes latest news stories, ...

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) Q1 2025 Earnings Call Transcript February 12, 2025 NeuroOne Medical Technologies Corporation beats earnings expectations. Reported EPS is ...